HER2 Overexpression Renders Human Breast Cancers Sensitive to PARP Inhibition Independently of Any Defect in Homologous Recombination DNA Repair
Cancer Research - United States
doi 10.1158/0008-5472.can-12-1287
Full Text
Open PDFAbstract
Available in full text
Date
September 15, 2012
Authors
Publisher
American Association for Cancer Research (AACR)